Share on StockTwits

NanoViricides (NASDAQ:NNVC) major shareholder Anil Diwan bought 50,000 shares of NanoViricides stock in a transaction that occurred on Thursday, February 20th. The stock was purchased at an average cost of $3.61 per share, for a total transaction of $180,500.00. Following the acquisition, the insider now directly owns 2,016,347 shares of the company’s stock, valued at approximately $7,279,013. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

NanoViricides (NASDAQ:NNVC) traded up 0.78% on Monday, hitting $3.89. 188,550 shares of the company’s stock traded hands. NanoViricides has a one year low of $1.225 and a one year high of $7.59. The stock has a 50-day moving average of $4.55 and a 200-day moving average of $4.82. The company’s market cap is $209.9 million.

NanoViricides, Incis a development-stage company. The Company is a nano-biopharmaceutical (NASDAQ:NNVC) company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life-threatening viral infections.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.